Dr. Ilan Joseph Safir, MD

Dr. Safir practices at Integrated Medical Professionals in Manhasset, New York.

Dr. Safir's NPI, 1174889760, was assigned on April 9, 2012. Dr. Safir graduated from University of California, Geffen School of Medicine in 2012. Dr. Safir holds New York license 287040.

Dr. Safir's primary practice is Integrated Medical Professionals, at 535 Plandome Rd, Manhasset, NY 11030 in Nassau County. The practice phone is (516) 931-0041.

Dr. Safir's primary practice is Integrated Medical Professionals in Manhasset, New York. Dr. Safir is also affiliated with North Shore University Hospital. The medical group on file is Integrated Medical Professionals. Dmand AI also links Dr. Safir to 4 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safir practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Safir's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Safir is licensed in New York.

CMS data shows 39,316 Medicare services from Dr. Safir across 41 procedure codes in 2024, for 1,638 Medicare patients. Medicare paid $571,197 for them.

CMS counts 1,638 Medicare patients who saw Dr. Safir in 2024. The largest group is 75 to 84, with 666 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Safir's median patient age at 74, with 28% women.

In 2024, Dr. Safir wrote 2,546 Medicare Part D claims for 726 patients. 91% of them were for generic drugs. CMS names the drug for 2,363 of them, across 28 drugs with 11 or more claims each, at $213,241 in total drug cost. In 2023, CMS named 2,797 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Safir for performance year 2024, reported as part of a group. Dr. Safir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Safir as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Safir, published from 2014 to 2017. 2015 was the busiest year, with 3. The most frequent topics are Prostatectomy and Urology. Dr. Safir has published most often in Urol Pract. Dr. Safir's most frequent co-authors are Christopher Paul Filson, MD, MS, Vitaly Zholudev, MD and Mehrdad E. Alemozaffar.

CMS Open Payments shows 531 general payments to Dr. Safir from 53 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 65% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,758.

Dr. Safir graduated from University of California, Geffen School of Medicine in 2012.